rs762551, CYP1A2

N. diseases: 23
Source: ALL
Disease N. SNPs d DSI v DPI v Chr Position Consequence Alleles Class AFEXOME AFGENOME Score vda EI vda N. PMIDs First Ref. Last Ref.
Caffeine related disorders
CUI: C0236734
Disease: Caffeine related disorders
56 0.701 0.400 15 74749576 intron variant C/A snv 0.67 0.100 0.909 11 2008 2019
Malignant Neoplasms
CUI: C0006826
Disease: Malignant Neoplasms
1641 0.701 0.400 15 74749576 intron variant C/A snv 0.67 0.060 1.000 6 2012 2016
Primary malignant neoplasm
CUI: C1306459
Disease: Primary malignant neoplasm
1374 0.701 0.400 15 74749576 intron variant C/A snv 0.67 0.060 1.000 6 2012 2016
Breast Carcinoma
CUI: C0678222
Disease: Breast Carcinoma
2793 0.701 0.400 15 74749576 intron variant C/A snv 0.67 0.050 1.000 5 2009 2019
Malignant neoplasm of breast
CUI: C0006142
Disease: Malignant neoplasm of breast
3417 0.701 0.400 15 74749576 intron variant C/A snv 0.67 0.050 1.000 5 2009 2019
Carcinoma of lung
CUI: C0684249
Disease: Carcinoma of lung
1204 0.701 0.400 15 74749576 intron variant C/A snv 0.67 0.040 1.000 4 2012 2014
Malignant neoplasm of lung
CUI: C0242379
Disease: Malignant neoplasm of lung
1142 0.701 0.400 15 74749576 intron variant C/A snv 0.67 0.040 1.000 4 2012 2014
Parkinson Disease
CUI: C0030567
Disease: Parkinson Disease
990 0.701 0.400 15 74749576 intron variant C/A snv 0.67 0.040 0.500 4 2010 2018
Primary malignant neoplasm of lung
CUI: C1306460
Disease: Primary malignant neoplasm of lung
981 0.701 0.400 15 74749576 intron variant C/A snv 0.67 0.040 1.000 4 2012 2014
Bladder Neoplasm
CUI: C0005695
Disease: Bladder Neoplasm
281 0.701 0.400 15 74749576 intron variant C/A snv 0.67 0.030 1.000 3 2015 2016
Carcinoma of bladder
CUI: C0699885
Disease: Carcinoma of bladder
309 0.701 0.400 15 74749576 intron variant C/A snv 0.67 0.030 1.000 3 2015 2016
Malignant neoplasm of urinary bladder
CUI: C0005684
Disease: Malignant neoplasm of urinary bladder
316 0.701 0.400 15 74749576 intron variant C/A snv 0.67 0.030 1.000 3 2015 2016
Colorectal Carcinoma
CUI: C0009402
Disease: Colorectal Carcinoma
1962 0.701 0.400 15 74749576 intron variant C/A snv 0.67 0.020 1.000 2 2013 2014
CYP1A2 polymorphism
CUI: C3888516
Disease: CYP1A2 polymorphism
2 0.701 0.400 15 74749576 intron variant C/A snv 0.67 0.020 1.000 2 2017 2019
Carcinogenesis
CUI: C0596263
Disease: Carcinogenesis
355 0.701 0.400 15 74749576 intron variant C/A snv 0.67 0.010 1.000 1 2014 2014
Cardiovascular Diseases
CUI: C0007222
Disease: Cardiovascular Diseases
711 0.701 0.400 15 74749576 intron variant C/A snv 0.67 0.010 1.000 1 2012 2012
Drug-induced tardive dyskinesia
CUI: C3714760
Disease: Drug-induced tardive dyskinesia
67 0.701 0.400 15 74749576 intron variant C/A snv 0.67 0.010 1.000 1 2015 2015
Essential Hypertension
CUI: C0085580
Disease: Essential Hypertension
293 0.701 0.400 15 74749576 intron variant C/A snv 0.67 0.010 1.000 1 2017 2017
Hypertensive disease
CUI: C0020538
Disease: Hypertensive disease
1085 0.701 0.400 15 74749576 intron variant C/A snv 0.67 0.010 1.000 1 2012 2012
Malignant neoplasm of colon and/or rectum
CUI: C4722085
Disease: Malignant neoplasm of colon and/or rectum
502 0.701 0.400 15 74749576 intron variant C/A snv 0.67 0.010 1.000 1 2014 2014
Neoplasms
CUI: C0027651
Disease: Neoplasms
1644 0.701 0.400 15 74749576 intron variant C/A snv 0.67 0.010 1.000 1 2016 2016
Squamous cell carcinoma of esophagus
CUI: C0279626
Disease: Squamous cell carcinoma of esophagus
329 0.701 0.400 15 74749576 intron variant C/A snv 0.67 0.010 1 2018 2018
Tardive Dyskinesia
CUI: C0686347
Disease: Tardive Dyskinesia
67 0.701 0.400 15 74749576 intron variant C/A snv 0.67 0.010 1.000 1 2015 2015